Statistical analysis was by One-way ANOVA (nonparametric) with Dunnetts post test unless otherwise stated in the figure legends
We also wish to thank Peter Ravn (MedImmune Ltd, Cambridge, UK) for intellectual input into GLP-1 analogue peptide stabilization, Bojana Popovic and Daniel Cannon (MedImmune Ltd, Cambridge, UK) for generating and analysing the peptide homology model, Adrian Podmore (MedImmune Ltd, Cambridge, UK) for conducting the aggregation and stability testing, Richard Kay (LGC, Fordham, UK) for conducting the mass spectrometry metabolites identification work, Marcella Petrone and John Hood (MedImmune Ltd, Cambridge, UK) for performing PK-PD simulations and analysis as well as Christopher Rhodes (MedImmune LLC, Gaithersburg, MD, USA) for his critical review of this manuscript
Further research needs to be done to include other people of other countries and ethnicities, says Moreno
High purity: We regularly test our retatrutide product through third-party laboratories
Types of GLP-1 Six agents are available in the EU market but only 3 have reached the Egyptian market (Exenatide, Liraglutide and Dulaglutide)